Applied DNA Sciences, Inc. (APDN) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Catalyst Biosciences, Inc.

Elutia, Inc.

22nd Century Group, Inc.

Applied DNA Sciences, Inc.

Microbot Medical, Inc.

Senti Biosciences, Inc.

BiomX, Inc.

NeuroBo Pharmaceuticals, Inc.

AquaBounty Technologies, Inc.

Orgenesis, Inc.

Vascular Biogenics Ltd.

Why is Applied DNA Sciences, Inc. ?

NET SALES(HY) At USD 0.76 MM has Grown at -61.94%
OPERATING CASH FLOW(Y) Lowest at USD -14.75 MM
ROCE(HY) Lowest at -194.93%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -97.70%, its profits have fallen by -77.9%

Below par performance in long term as well as near term

Along with generating -97.70% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Applied DNA Sciences, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Applied DNA Sciences, Inc.

-97.84%

-0.06

1639.85%

S&P 500

13.68%

0.71

19.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-6.77%

EBIT Growth (5y)

-32.19%

EBIT to Interest (avg)

-12.95

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.61

Sales to Capital Employed (avg)

1.27

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

3.61%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.22

EV to EBIT

-0.04

EV to EBITDA

-0.05

EV to Capital Employed

0.07

EV to Sales

0.52

PEG Ratio

Dividend Yield

ROCE (Latest)

-152.67%

ROE (Latest)

-122.75%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bullish

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

EPS(Q)

Highest at USD -2.08

-35What is not working for the Company

NET SALES(HY)

At USD 0.76 MM has Grown at -61.94%

OPERATING CASH FLOW(Y)

Lowest at USD -14.75 MM

ROCE(HY)

Lowest at -194.93%

NET PROFIT(Q)

Lowest at USD -13.38 MM

RAW MATERIAL COST(Y)

Grown by 28.6% (YoY

CASH AND EQV(HY)

Lowest at USD 4.87 MM

DEBT-EQUITY RATIO (HY)

Highest at -16.73 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.82 times

OPERATING PROFIT(Q)

Lowest at USD -13.44 MM

PRE-TAX PROFIT(Q)

Lowest at USD -13.39 MM

Here's what is working for Applied DNA Sciences, Inc.

EPS

Highest at USD -2.08

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Here's what is not working for Applied DNA Sciences, Inc.

Net Sales

At USD 0.76 MM has Grown at -61.94%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Pre-Tax Profit

At USD -13.39 MM has Fallen at -301.85%

over average net sales of the previous four periods of USD -3.33 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

At USD -13.38 MM has Fallen at -329.6%

over average net sales of the previous four periods of USD -3.11 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Cash Flow

Lowest at USD -14.75 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Net Profit

Lowest at USD -13.38 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Operating Profit

Lowest at USD -13.44 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (USD MM)

Pre-Tax Profit

Lowest at USD -13.39 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Cash and Eqv

Lowest at USD 4.87 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -16.73 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 2.82 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 28.6% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales